Clinical trial · people

Pancragen lowered blood sugar and insulin in older type 2 diabetes

Checked against the paper Clinical trialPublished by PepVault

The takeaway

This is an early, small human study in which pancragen lowered blood sugar and insulin measures in older people with type 2 diabetes, but it is not strong proof on its own.

Kind
Clinical trial
Studied in
People
Published
2011
Journal
Bull Exp Biol Med

What they tested

The team set out to test whether the tetrapeptide pancragen could improve blood sugar control and insulin resistance in older people with type 2 diabetes.

How the study was done

A small clinical study in older adults: 30 healthy people and 33 patients with type 2 diabetes. Some of the patients with diabetes were given pancragen and were compared with patients who did not receive it.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking pancragen? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

At night, the patients with type 2 diabetes made 70% less melatonin, a sleep-linked hormone, than healthy people of the same age. In the patients given pancragen, fasting blood sugar fell, and so did blood sugar during a standard glucose tolerance test (a drink-and-measure sugar test). Their plasma insulin and their insulin resistance index (a measure of how poorly the body responds to insulin) also went down. Patients who did not get pancragen showed no change in these blood sugar measures.

What it doesn’t show

This was a small study in older adults that compared patients given pancragen with patients who got none. It does not show how long the effects last or how pancragen compares with standard diabetes care.

The paper

Korkushko et al. Prospects of using pancragen for correction of metabolic disorders in elderly people. Bull Exp Biol Med. 2011.

The compound

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking pancragen? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo